A PHP Error was encountered

Severity: Warning

Message: fopen(/var/cpanel/php/sessions/ea-php72/ci_session3db7ad3b3b1de5e3297551e8567407fbe34d6d38): failed to open stream: No space left on device

Filename: drivers/Session_files_driver.php

Line Number: 176

Backtrace:

File: /home/rejovjcx/mraccuracyreports.com/application/controllers/Reportdetails.php
Line: 10
Function: library

File: /home/rejovjcx/mraccuracyreports.com/index.php
Line: 315
Function: require_once

A PHP Error was encountered

Severity: Warning

Message: session_start(): Failed to read session data: user (path: /var/cpanel/php/sessions/ea-php72)

Filename: Session/Session.php

Line Number: 143

Backtrace:

File: /home/rejovjcx/mraccuracyreports.com/application/controllers/Reportdetails.php
Line: 10
Function: library

File: /home/rejovjcx/mraccuracyreports.com/index.php
Line: 315
Function: require_once

Global K Cells Market Insights, Forecast to 2034

img

Global K Cells Market Insights, Forecast to 2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global K Cells Market Insights, Forecast to 2034

Global K Cells market is expected to reach to US$ million in 2023, with a positive growth of %, compared with US$ million in 2022. Backed with the increasing demand from downstream industries, K Cells industry is evaluated to reach US$ million in 2033. The CAGR will be % during 2023 to 2033.
Globally, K Cells key manufacturers include Chipscreen Biosciences, Affimed NV, Altor BioScience, Innate Pharma, Takeda, Sorrento Therapeutics, NantKwest, Bristol-Myers Squibb and NKT, etc. Chipscreen Biosciences, Affimed NV, Altor BioScience are top 3 players and held % sales share in total in 2022.
When considering the consumption regions, % volume of K Cells were sold to North America, Europe and Asia Pacific in 2022. Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2033 and the sales share will be % in 2033. Moreover, China, plays a key role in the whole K Cells market and estimated to attract more attentions from industry insiders and investors.
K Cells can be divided into Mogamulizumab, Lorvotuzumab Mertansine and Others,, etc. Mogamulizumab is the mainstream product in the market, accounting for % sales share globally in 2022 and the proportion will be % in 2033.
K Cells is widely used in various fields, such as Cancer, Cardiovascular Diseases and Others,, etc. Cancer provides greatest supports to the K Cells industry development. In 2022, global % sales of K Cells went into Cancer filed and the proportion will reach to % in 2033.
Report Covers
This report presents an overview of global K Cells market from 2018 to 2033, aiming to help readers to get a comprehensive understanding of global K Cells market with multiple angles. Items like regional sales, revenue from 2018 to 2033 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2023 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2033 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Chipscreen Biosciences
Affimed NV
Altor BioScience
Innate Pharma
Takeda
Sorrento Therapeutics
NantKwest
Bristol-Myers Squibb
NKT
Henry Ford Health Services
Segment by Type
Mogamulizumab
Lorvotuzumab Mertansine
Others

Segment by Application


Cancer
Cardiovascular Diseases
Others

Segment by Region


US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2033
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ K Cells plant distribution, commercial date of K Cells, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2033 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2033 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2033 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2033
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2033 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2033
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2033 in China. Product sales and revenue analysis of China from 2018 to 2033
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2033 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2033
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2033 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2033.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, K Cells introduction, etc. K Cells Sales, Revenue, Price and Gross Margin of each company from 2018 to 2023
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14MRAResearch’s Conclusions of K Cells
Chapter 15Methodology and Data Sources adopted by MRAResearch

Table of Content

1 Study Coverage
1.1 K Cells Product Introduction
1.2 Market by Type
1.2.1 Global K Cells Market Size Growth Rate by Type, 2018 VS 2022 VS 2033
1.2.2 Mogamulizumab
1.2.3 Lorvotuzumab Mertansine
1.2.4 Others
1.3 Market by Application
1.3.1 Global K Cells Market Size Growth Rate by Application, 2018 VS 2022 VS 2033
1.3.2 Cancer
1.3.3 Cardiovascular Diseases
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global K Cells Sales Estimates and Forecasts 2018-2033
2.2 Global K Cells Revenue by Region
2.2.1 Global K Cells Revenue by Region: 2018 VS 2022 VS 2033
2.2.2 Global K Cells Revenue by Region (2018-2023)
2.2.3 Global K Cells Revenue by Region (2024-2033)
2.2.4 Global K Cells Revenue Market Share by Region (2018-2033)
2.3 Global K Cells Sales Estimates and Forecasts 2018-2033
2.4 Global K Cells Sales by Region
2.4.1 Global K Cells Sales by Region: 2018 VS 2022 VS 2033
2.4.2 Global K Cells Sales by Region (2018-2023)
2.4.3 Global K Cells Sales by Region (2024-2033)
2.4.4 Global K Cells Sales Market Share by Region (2018-2033)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global K Cells Sales by Manufacturers
3.1.1 Global K Cells Sales by Manufacturers (2018-2023)
3.1.2 Global K Cells Sales Market Share by Manufacturers (2018-2023)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of K Cells in 2022
3.2 Global K Cells Revenue by Manufacturers
3.2.1 Global K Cells Revenue by Manufacturers (2018-2023)
3.2.2 Global K Cells Revenue Market Share by Manufacturers (2018-2023)
3.2.3 Global Top 10 and Top 5 Companies by K Cells Revenue in 2022
3.3 Global Key Players of K Cells, Industry Ranking, 2021 VS 2022 VS 2023
3.4 Global K Cells Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global K Cells Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of K Cells, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of K Cells, Product Offered and Application
3.8 Global Key Manufacturers of K Cells, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global K Cells Sales by Type
4.1.1 Global K Cells Historical Sales by Type (2018-2023)
4.1.2 Global K Cells Forecasted Sales by Type (2024-2033)
4.1.3 Global K Cells Sales Market Share by Type (2018-2033)
4.2 Global K Cells Revenue by Type
4.2.1 Global K Cells Historical Revenue by Type (2018-2023)
4.2.2 Global K Cells Forecasted Revenue by Type (2024-2033)
4.2.3 Global K Cells Revenue Market Share by Type (2018-2033)
4.3 Global K Cells Price by Type
4.3.1 Global K Cells Price by Type (2018-2023)
4.3.2 Global K Cells Price Forecast by Type (2024-2033)
5 Market Size by Application
5.1 Global K Cells Sales by Application
5.1.1 Global K Cells Historical Sales by Application (2018-2023)
5.1.2 Global K Cells Forecasted Sales by Application (2024-2033)
5.1.3 Global K Cells Sales Market Share by Application (2018-2033)
5.2 Global K Cells Revenue by Application
5.2.1 Global K Cells Historical Revenue by Application (2018-2023)
5.2.2 Global K Cells Forecasted Revenue by Application (2024-2033)
5.2.3 Global K Cells Revenue Market Share by Application (2018-2033)
5.3 Global K Cells Price by Application
5.3.1 Global K Cells Price by Application (2018-2023)
5.3.2 Global K Cells Price Forecast by Application (2024-2033)
6 US & Canada
6.1 US & Canada K Cells Market Size by Type
6.1.1 US & Canada K Cells Sales by Type (2018-2033)
6.1.2 US & Canada K Cells Revenue by Type (2018-2033)
6.2 US & Canada K Cells Market Size by Application
6.2.1 US & Canada K Cells Sales by Application (2018-2033)
6.2.2 US & Canada K Cells Revenue by Application (2018-2033)
6.3 US & Canada K Cells Market Size by Country
6.3.1 US & Canada K Cells Revenue by Country: 2018 VS 2022 VS 2033
6.3.2 US & Canada K Cells Sales by Country (2018-2033)
6.3.3 US & Canada K Cells Revenue by Country (2018-2033)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe K Cells Market Size by Type
7.1.1 Europe K Cells Sales by Type (2018-2033)
7.1.2 Europe K Cells Revenue by Type (2018-2033)
7.2 Europe K Cells Market Size by Application
7.2.1 Europe K Cells Sales by Application (2018-2033)
7.2.2 Europe K Cells Revenue by Application (2018-2033)
7.3 Europe K Cells Market Size by Country
7.3.1 Europe K Cells Revenue by Country: 2018 VS 2022 VS 2033
7.3.2 Europe K Cells Sales by Country (2018-2033)
7.3.3 Europe K Cells Revenue by Country (2018-2033)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China K Cells Market Size
8.1.1 China K Cells Sales (2018-2033)
8.1.2 China K Cells Revenue (2018-2033)
8.2 China K Cells Market Size by Application
8.2.1 China K Cells Sales by Application (2018-2033)
8.2.2 China K Cells Revenue by Application (2018-2033)
9 Asia (excluding China)
9.1 Asia K Cells Market Size by Type
9.1.1 Asia K Cells Sales by Type (2018-2033)
9.1.2 Asia K Cells Revenue by Type (2018-2033)
9.2 Asia K Cells Market Size by Application
9.2.1 Asia K Cells Sales by Application (2018-2033)
9.2.2 Asia K Cells Revenue by Application (2018-2033)
9.3 Asia K Cells Sales by Region
9.3.1 Asia K Cells Revenue by Region: 2018 VS 2022 VS 2033
9.3.2 Asia K Cells Revenue by Region (2018-2033)
9.3.3 Asia K Cells Sales by Region (2018-2033)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America K Cells Market Size by Type
10.1.1 Middle East, Africa and Latin America K Cells Sales by Type (2018-2033)
10.1.2 Middle East, Africa and Latin America K Cells Revenue by Type (2018-2033)
10.2 Middle East, Africa and Latin America K Cells Market Size by Application
10.2.1 Middle East, Africa and Latin America K Cells Sales by Application (2018-2033)
10.2.2 Middle East, Africa and Latin America K Cells Revenue by Application (2018-2033)
10.3 Middle East, Africa and Latin America K Cells Sales by Country
10.3.1 Middle East, Africa and Latin America K Cells Revenue by Country: 2018 VS 2022 VS 2033
10.3.2 Middle East, Africa and Latin America K Cells Revenue by Country (2018-2033)
10.3.3 Middle East, Africa and Latin America K Cells Sales by Country (2018-2033)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Chipscreen Biosciences
11.1.1 Chipscreen Biosciences Company Information
11.1.2 Chipscreen Biosciences Overview
11.1.3 Chipscreen Biosciences K Cells Sales, Price, Revenue and Gross Margin (2018-2023)
11.1.4 Chipscreen Biosciences K Cells Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Chipscreen Biosciences Recent Developments
11.2 Affimed NV
11.2.1 Affimed NV Company Information
11.2.2 Affimed NV Overview
11.2.3 Affimed NV K Cells Sales, Price, Revenue and Gross Margin (2018-2023)
11.2.4 Affimed NV K Cells Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Affimed NV Recent Developments
11.3 Altor BioScience
11.3.1 Altor BioScience Company Information
11.3.2 Altor BioScience Overview
11.3.3 Altor BioScience K Cells Sales, Price, Revenue and Gross Margin (2018-2023)
11.3.4 Altor BioScience K Cells Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Altor BioScience Recent Developments
11.4 Innate Pharma
11.4.1 Innate Pharma Company Information
11.4.2 Innate Pharma Overview
11.4.3 Innate Pharma K Cells Sales, Price, Revenue and Gross Margin (2018-2023)
11.4.4 Innate Pharma K Cells Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Innate Pharma Recent Developments
11.5 Takeda
11.5.1 Takeda Company Information
11.5.2 Takeda Overview
11.5.3 Takeda K Cells Sales, Price, Revenue and Gross Margin (2018-2023)
11.5.4 Takeda K Cells Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Takeda Recent Developments
11.6 Sorrento Therapeutics
11.6.1 Sorrento Therapeutics Company Information
11.6.2 Sorrento Therapeutics Overview
11.6.3 Sorrento Therapeutics K Cells Sales, Price, Revenue and Gross Margin (2018-2023)
11.6.4 Sorrento Therapeutics K Cells Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Sorrento Therapeutics Recent Developments
11.7 NantKwest
11.7.1 NantKwest Company Information
11.7.2 NantKwest Overview
11.7.3 NantKwest K Cells Sales, Price, Revenue and Gross Margin (2018-2023)
11.7.4 NantKwest K Cells Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 NantKwest Recent Developments
11.8 Bristol-Myers Squibb
11.8.1 Bristol-Myers Squibb Company Information
11.8.2 Bristol-Myers Squibb Overview
11.8.3 Bristol-Myers Squibb K Cells Sales, Price, Revenue and Gross Margin (2018-2023)
11.8.4 Bristol-Myers Squibb K Cells Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Bristol-Myers Squibb Recent Developments
11.9 NKT
11.9.1 NKT Company Information
11.9.2 NKT Overview
11.9.3 NKT K Cells Sales, Price, Revenue and Gross Margin (2018-2023)
11.9.4 NKT K Cells Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 NKT Recent Developments
11.10 Henry Ford Health Services
11.10.1 Henry Ford Health Services Company Information
11.10.2 Henry Ford Health Services Overview
11.10.3 Henry Ford Health Services K Cells Sales, Price, Revenue and Gross Margin (2018-2023)
11.10.4 Henry Ford Health Services K Cells Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Henry Ford Health Services Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 K Cells Industry Chain Analysis
12.2 K Cells Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 K Cells Production Mode & Process
12.4 K Cells Sales and Marketing
12.4.1 K Cells Sales Channels
12.4.2 K Cells Distributors
12.5 K Cells Customers
13 Market Dynamics
13.1 K Cells Industry Trends
13.2 K Cells Market Drivers
13.3 K Cells Market Challenges
13.4 K Cells Market Restraints
14 Key Findings in The Global K Cells Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global K Cells Market Size Growth Rate by Type, 2018 VS 2022 VS 2033 (US$ Million)
Table 2. Major Manufacturers of Mogamulizumab
Table 3. Major Manufacturers of Lorvotuzumab Mertansine
Table 4. Major Manufacturers of Others
Table 5. Global K Cells Market Size Growth Rate by Application, 2018 VS 2022 VS 2033 (US$ Million)
Table 6. Global K Cells Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2033 (US$ Million)
Table 7. Global K Cells Revenue by Region (2018-2023) & (US$ Million)
Table 8. Global K Cells Revenue by Region (2024-2033) & (US$ Million)
Table 9. Global K Cells Revenue Market Share by Region (2018-2023)
Table 10. Global K Cells Revenue Market Share by Region (2024-2033)
Table 11. Global K Cells Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2033 (US$ Million)
Table 12. Global K Cells Sales by Region (2018-2023) & (g)
Table 13. Global K Cells Sales by Region (2024-2033) & (g)
Table 14. Global K Cells Sales Market Share by Region (2018-2023)
Table 15. Global K Cells Sales Market Share by Region (2024-2033)
Table 16. Global K Cells Sales by Manufacturers (2018-2023) & (g)
Table 17. Global K Cells Sales Share by Manufacturers (2018-2023)
Table 18. Global K Cells Revenue by Manufacturers (2018-2023) & (US$ Million)
Table 19. Global K Cells Revenue Share by Manufacturers (2018-2023)
Table 20. Global Key Players of K Cells, Industry Ranking, 2021 VS 2022 VS 2023
Table 21. K Cells Price by Manufacturers 2018-2023 (USD/g)
Table 22. Global K Cells Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 23. Global K Cells by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in K Cells as of 2022)
Table 24. Global Key Manufacturers of K Cells, Manufacturing Base Distribution and Headquarters
Table 25. Global Key Manufacturers of K Cells, Product Offered and Application
Table 26. Global Key Manufacturers of K Cells, Date of Enter into This Industry
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global K Cells Sales by Type (2018-2023) & (g)
Table 29. Global K Cells Sales by Type (2024-2033) & (g)
Table 30. Global K Cells Sales Share by Type (2018-2023)
Table 31. Global K Cells Sales Share by Type (2024-2033)
Table 32. Global K Cells Revenue by Type (2018-2023) & (US$ Million)
Table 33. Global K Cells Revenue by Type (2024-2033) & (US$ Million)
Table 34. Global K Cells Revenue Share by Type (2018-2023)
Table 35. Global K Cells Revenue Share by Type (2024-2033)
Table 36. K Cells Price by Type (2018-2023) & (USD/g)
Table 37. Global K Cells Price Forecast by Type (2024-2033) & (USD/g)
Table 38. Global K Cells Sales by Application (2018-2023) & (g)
Table 39. Global K Cells Sales by Application (2024-2033) & (g)
Table 40. Global K Cells Sales Share by Application (2018-2023)
Table 41. Global K Cells Sales Share by Application (2024-2033)
Table 42. Global K Cells Revenue by Application (2018-2023) & (US$ Million)
Table 43. Global K Cells Revenue by Application (2024-2033) & (US$ Million)
Table 44. Global K Cells Revenue Share by Application (2018-2023)
Table 45. Global K Cells Revenue Share by Application (2024-2033)
Table 46. K Cells Price by Application (2018-2023) & (USD/g)
Table 47. Global K Cells Price Forecast by Application (2024-2033) & (USD/g)
Table 48. US & Canada K Cells Sales by Type (2018-2023) & (g)
Table 49. US & Canada K Cells Sales by Type (2024-2033) & (g)
Table 50. US & Canada K Cells Revenue by Type (2018-2023) & (US$ Million)
Table 51. US & Canada K Cells Revenue by Type (2024-2033) & (US$ Million)
Table 52. US & Canada K Cells Sales by Application (2018-2023) & (g)
Table 53. US & Canada K Cells Sales by Application (2024-2033) & (g)
Table 54. US & Canada K Cells Revenue by Application (2018-2023) & (US$ Million)
Table 55. US & Canada K Cells Revenue by Application (2024-2033) & (US$ Million)
Table 56. US & Canada K Cells Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2033 (US$ Million)
Table 57. US & Canada K Cells Revenue by Country (2018-2023) & (US$ Million)
Table 58. US & Canada K Cells Revenue by Country (2024-2033) & (US$ Million)
Table 59. US & Canada K Cells Sales by Country (2018-2023) & (g)
Table 60. US & Canada K Cells Sales by Country (2024-2033) & (g)
Table 61. Europe K Cells Sales by Type (2018-2023) & (g)
Table 62. Europe K Cells Sales by Type (2024-2033) & (g)
Table 63. Europe K Cells Revenue by Type (2018-2023) & (US$ Million)
Table 64. Europe K Cells Revenue by Type (2024-2033) & (US$ Million)
Table 65. Europe K Cells Sales by Application (2018-2023) & (g)
Table 66. Europe K Cells Sales by Application (2024-2033) & (g)
Table 67. Europe K Cells Revenue by Application (2018-2023) & (US$ Million)
Table 68. Europe K Cells Revenue by Application (2024-2033) & (US$ Million)
Table 69. Europe K Cells Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2033 (US$ Million)
Table 70. Europe K Cells Revenue by Country (2018-2023) & (US$ Million)
Table 71. Europe K Cells Revenue by Country (2024-2033) & (US$ Million)
Table 72. Europe K Cells Sales by Country (2018-2023) & (g)
Table 73. Europe K Cells Sales by Country (2024-2033) & (g)
Table 74. China K Cells Sales by Type (2018-2023) & (g)
Table 75. China K Cells Sales by Type (2024-2033) & (g)
Table 76. China K Cells Revenue by Type (2018-2023) & (US$ Million)
Table 77. China K Cells Revenue by Type (2024-2033) & (US$ Million)
Table 78. China K Cells Sales by Application (2018-2023) & (g)
Table 79. China K Cells Sales by Application (2024-2033) & (g)
Table 80. China K Cells Revenue by Application (2018-2023) & (US$ Million)
Table 81. China K Cells Revenue by Application (2024-2033) & (US$ Million)
Table 82. Asia K Cells Sales by Type (2018-2023) & (g)
Table 83. Asia K Cells Sales by Type (2024-2033) & (g)
Table 84. Asia K Cells Revenue by Type (2018-2023) & (US$ Million)
Table 85. Asia K Cells Revenue by Type (2024-2033) & (US$ Million)
Table 86. Asia K Cells Sales by Application (2018-2023) & (g)
Table 87. Asia K Cells Sales by Application (2024-2033) & (g)
Table 88. Asia K Cells Revenue by Application (2018-2023) & (US$ Million)
Table 89. Asia K Cells Revenue by Application (2024-2033) & (US$ Million)
Table 90. Asia K Cells Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2033 (US$ Million)
Table 91. Asia K Cells Revenue by Region (2018-2023) & (US$ Million)
Table 92. Asia K Cells Revenue by Region (2024-2033) & (US$ Million)
Table 93. Asia K Cells Sales by Region (2018-2023) & (g)
Table 94. Asia K Cells Sales by Region (2024-2033) & (g)
Table 95. Middle East, Africa and Latin America K Cells Sales by Type (2018-2023) & (g)
Table 96. Middle East, Africa and Latin America K Cells Sales by Type (2024-2033) & (g)
Table 97. Middle East, Africa and Latin America K Cells Revenue by Type (2018-2023) & (US$ Million)
Table 98. Middle East, Africa and Latin America K Cells Revenue by Type (2024-2033) & (US$ Million)
Table 99. Middle East, Africa and Latin America K Cells Sales by Application (2018-2023) & (g)
Table 100. Middle East, Africa and Latin America K Cells Sales by Application (2024-2033) & (g)
Table 101. Middle East, Africa and Latin America K Cells Revenue by Application (2018-2023) & (US$ Million)
Table 102. Middle East, Africa and Latin America K Cells Revenue by Application (2024-2033) & (US$ Million)
Table 103. Middle East, Africa and Latin America K Cells Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2033 (US$ Million)
Table 104. Middle East, Africa and Latin America K Cells Revenue by Country (2018-2023) & (US$ Million)
Table 105. Middle East, Africa and Latin America K Cells Revenue by Country (2024-2033) & (US$ Million)
Table 106. Middle East, Africa and Latin America K Cells Sales by Country (2018-2023) & (g)
Table 107. Middle East, Africa and Latin America K Cells Sales by Country (2024-2033) & (g)
Table 108. Chipscreen Biosciences Company Information
Table 109. Chipscreen Biosciences Description and Major Businesses
Table 110. Chipscreen Biosciences K Cells Sales (g), Revenue (US$ Million), Price (USD/g) and Gross Margin (2018-2023)
Table 111. Chipscreen Biosciences K Cells Product Model Numbers, Pictures, Descriptions and Specifications
Table 112. Chipscreen Biosciences Recent Developments
Table 113. Affimed NV Company Information
Table 114. Affimed NV Description and Major Businesses
Table 115. Affimed NV K Cells Sales (g), Revenue (US$ Million), Price (USD/g) and Gross Margin (2018-2023)
Table 116. Affimed NV K Cells Product Model Numbers, Pictures, Descriptions and Specifications
Table 117. Affimed NV Recent Developments
Table 118. Altor BioScience Company Information
Table 119. Altor BioScience Description and Major Businesses
Table 120. Altor BioScience K Cells Sales (g), Revenue (US$ Million), Price (USD/g) and Gross Margin (2018-2023)
Table 121. Altor BioScience K Cells Product Model Numbers, Pictures, Descriptions and Specifications
Table 122. Altor BioScience Recent Developments
Table 123. Innate Pharma Company Information
Table 124. Innate Pharma Description and Major Businesses
Table 125. Innate Pharma K Cells Sales (g), Revenue (US$ Million), Price (USD/g) and Gross Margin (2018-2023)
Table 126. Innate Pharma K Cells Product Model Numbers, Pictures, Descriptions and Specifications
Table 127. Innate Pharma Recent Developments
Table 128. Takeda Company Information
Table 129. Takeda Description and Major Businesses
Table 130. Takeda K Cells Sales (g), Revenue (US$ Million), Price (USD/g) and Gross Margin (2018-2023)
Table 131. Takeda K Cells Product Model Numbers, Pictures, Descriptions and Specifications
Table 132. Takeda Recent Developments
Table 133. Sorrento Therapeutics Company Information
Table 134. Sorrento Therapeutics Description and Major Businesses
Table 135. Sorrento Therapeutics K Cells Sales (g), Revenue (US$ Million), Price (USD/g) and Gross Margin (2018-2023)
Table 136. Sorrento Therapeutics K Cells Product Model Numbers, Pictures, Descriptions and Specifications
Table 137. Sorrento Therapeutics Recent Developments
Table 138. NantKwest Company Information
Table 139. NantKwest Description and Major Businesses
Table 140. NantKwest K Cells Sales (g), Revenue (US$ Million), Price (USD/g) and Gross Margin (2018-2023)
Table 141. NantKwest K Cells Product Model Numbers, Pictures, Descriptions and Specifications
Table 142. NantKwest Recent Developments
Table 143. Bristol-Myers Squibb Company Information
Table 144. Bristol-Myers Squibb Description and Major Businesses
Table 145. Bristol-Myers Squibb K Cells Sales (g), Revenue (US$ Million), Price (USD/g) and Gross Margin (2018-2023)
Table 146. Bristol-Myers Squibb K Cells Product Model Numbers, Pictures, Descriptions and Specifications
Table 147. Bristol-Myers Squibb Recent Developments
Table 148. NKT Company Information
Table 149. NKT Description and Major Businesses
Table 150. NKT K Cells Sales (g), Revenue (US$ Million), Price (USD/g) and Gross Margin (2018-2023)
Table 151. NKT K Cells Product Model Numbers, Pictures, Descriptions and Specifications
Table 152. NKT Recent Developments
Table 153. Henry Ford Health Services Company Information
Table 154. Henry Ford Health Services Description and Major Businesses
Table 155. Henry Ford Health Services K Cells Sales (g), Revenue (US$ Million), Price (USD/g) and Gross Margin (2018-2023)
Table 156. Henry Ford Health Services K Cells Product Model Numbers, Pictures, Descriptions and Specifications
Table 157. Henry Ford Health Services Recent Developments
Table 158. Key Raw Materials Lists
Table 159. Raw Materials Key Suppliers Lists
Table 160. K Cells Distributors List
Table 161. K Cells Customers List
Table 162. K Cells Market Trends
Table 163. K Cells Market Drivers
Table 164. K Cells Market Challenges
Table 165. K Cells Market Restraints
Table 166. Research Programs/Design for This Report
Table 167. Key Data Information from Secondary Sources
Table 168. Key Data Information from Primary Sources
List of Figures
Figure 1. K Cells Product Picture
Figure 2. Global K Cells Market Size Growth Rate by Type, 2018 VS 2022 VS 2033 (US$ Million)
Figure 3. Global K Cells Market Share by Type in 2022 & 2033
Figure 4. Mogamulizumab Product Picture
Figure 5. Lorvotuzumab Mertansine Product Picture
Figure 6. Others Product Picture
Figure 7. Global K Cells Market Size Growth Rate by Application, 2018 VS 2022 VS 2033 (US$ Million)
Figure 8. Global K Cells Market Share by Application in 2022 & 2033
Figure 9. Cancer
Figure 10. Cardiovascular Diseases
Figure 11. Others
Figure 12. K Cells Report Years Considered
Figure 13. Global K Cells Revenue, (US$ Million), 2018 VS 2022 VS 2033
Figure 14. Global K Cells Revenue 2018-2033 (US$ Million)
Figure 15. Global K Cells Revenue Market Share by Region in Percentage: 2022 Versus 2033
Figure 16. Global K Cells Revenue Market Share by Region (2018-2033)
Figure 17. Global K Cells Sales 2018-2033 ((g)
Figure 18. Global K Cells Sales Market Share by Region (2018-2033)
Figure 19. US & Canada K Cells Sales YoY (2018-2033) & (g)
Figure 20. US & Canada K Cells Revenue YoY (2018-2033) & (US$ Million)
Figure 21. Europe K Cells Sales YoY (2018-2033) & (g)
Figure 22. Europe K Cells Revenue YoY (2018-2033) & (US$ Million)
Figure 23. China K Cells Sales YoY (2018-2033) & (g)
Figure 24. China K Cells Revenue YoY (2018-2033) & (US$ Million)
Figure 25. Asia (excluding China) K Cells Sales YoY (2018-2033) & (g)
Figure 26. Asia (excluding China) K Cells Revenue YoY (2018-2033) & (US$ Million)
Figure 27. Middle East, Africa and Latin America K Cells Sales YoY (2018-2033) & (g)
Figure 28. Middle East, Africa and Latin America K Cells Revenue YoY (2018-2033) & (US$ Million)
Figure 29. The K Cells Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 30. The Top 5 and 10 Largest Manufacturers of K Cells in the World: Market Share by K Cells Revenue in 2022
Figure 31. Global K Cells Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 32. Global K Cells Sales Market Share by Type (2018-2033)
Figure 33. Global K Cells Revenue Market Share by Type (2018-2033)
Figure 34. Global K Cells Sales Market Share by Application (2018-2033)
Figure 35. Global K Cells Revenue Market Share by Application (2018-2033)
Figure 36. US & Canada K Cells Sales Market Share by Type (2018-2033)
Figure 37. US & Canada K Cells Revenue Market Share by Type (2018-2033)
Figure 38. US & Canada K Cells Sales Market Share by Application (2018-2033)
Figure 39. US & Canada K Cells Revenue Market Share by Application (2018-2033)
Figure 40. US & Canada K Cells Revenue Share by Country (2018-2033)
Figure 41. US & Canada K Cells Sales Share by Country (2018-2033)
Figure 42. U.S. K Cells Revenue (2018-2033) & (US$ Million)
Figure 43. Canada K Cells Revenue (2018-2033) & (US$ Million)
Figure 44. Europe K Cells Sales Market Share by Type (2018-2033)
Figure 45. Europe K Cells Revenue Market Share by Type (2018-2033)
Figure 46. Europe K Cells Sales Market Share by Application (2018-2033)
Figure 47. Europe K Cells Revenue Market Share by Application (2018-2033)
Figure 48. Europe K Cells Revenue Share by Country (2018-2033)
Figure 49. Europe K Cells Sales Share by Country (2018-2033)
Figure 50. Germany K Cells Revenue (2018-2033) & (US$ Million)
Figure 51. France K Cells Revenue (2018-2033) & (US$ Million)
Figure 52. U.K. K Cells Revenue (2018-2033) & (US$ Million)
Figure 53. Italy K Cells Revenue (2018-2033) & (US$ Million)
Figure 54. Russia K Cells Revenue (2018-2033) & (US$ Million)
Figure 55. China K Cells Sales Market Share by Type (2018-2033)
Figure 56. China K Cells Revenue Market Share by Type (2018-2033)
Figure 57. China K Cells Sales Market Share by Application (2018-2033)
Figure 58. China K Cells Revenue Market Share by Application (2018-2033)
Figure 59. Asia K Cells Sales Market Share by Type (2018-2033)
Figure 60. Asia K Cells Revenue Market Share by Type (2018-2033)
Figure 61. Asia K Cells Sales Market Share by Application (2018-2033)
Figure 62. Asia K Cells Revenue Market Share by Application (2018-2033)
Figure 63. Asia K Cells Revenue Share by Region (2018-2033)
Figure 64. Asia K Cells Sales Share by Region (2018-2033)
Figure 65. Japan K Cells Revenue (2018-2033) & (US$ Million)
Figure 66. South Korea K Cells Revenue (2018-2033) & (US$ Million)
Figure 67. China Taiwan K Cells Revenue (2018-2033) & (US$ Million)
Figure 68. Southeast Asia K Cells Revenue (2018-2033) & (US$ Million)
Figure 69. India K Cells Revenue (2018-2033) & (US$ Million)
Figure 70. Middle East, Africa and Latin America K Cells Sales Market Share by Type (2018-2033)
Figure 71. Middle East, Africa and Latin America K Cells Revenue Market Share by Type (2018-2033)
Figure 72. Middle East, Africa and Latin America K Cells Sales Market Share by Application (2018-2033)
Figure 73. Middle East, Africa and Latin America K Cells Revenue Market Share by Application (2018-2033)
Figure 74. Middle East, Africa and Latin America K Cells Revenue Share by Country (2018-2033)
Figure 75. Middle East, Africa and Latin America K Cells Sales Share by Country (2018-2033)
Figure 76. Brazil K Cells Revenue (2018-2033) & (US$ Million)
Figure 77. Mexico K Cells Revenue (2018-2033) & (US$ Million)
Figure 78. Turkey K Cells Revenue (2018-2033) & (US$ Million)
Figure 79. Israel K Cells Revenue (2018-2033) & (US$ Million)
Figure 80. GCC Countries K Cells Revenue (2018-2033) & (US$ Million)
Figure 81. K Cells Value Chain
Figure 82. K Cells Production Process
Figure 83. Channels of Distribution
Figure 84. Distributors Profiles
Figure 85. Bottom-up and Top-down Approaches for This Report
Figure 86. Data Triangulation
Figure 87. Key Executives Interviewed